restless legs

Showing 2 posts of 2 posts found.

GSK delays US filing of Solzira

November 14, 2008
Sales and Marketing GSK, restless legs

GlaxoSmithKline has withdrawn the US application for its restless legs syndrome treatment Solzira. The company, along with co-developer XenoPort, is …

The Gateway to Local Adoption Series

Latest content